Abstract
Incurred sample reanalysis (ISR) is accepted as both a fundamental concept and an integral part in the conduct of pharmacokinetic, bioequivalence and preclinical safety studies. Reproducibility demonstrated by ISR reinforces confidence that the method is valid and the results dependable. In this article, the history of the uptake of ISR is discussed and the current practices described. The industry is given credit for its awareness of the importance of, and implementation of, ISR practices in bioanalytical laboratories. Finally, in the context of the recent publication of guidelines for ISR by the EMA, implications for globalization and harmonization of regulations pertaining to ISR are described.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
